Treatment with tenofovir disoproxil fumarate (TDF) was found to be effective in reducing the occurrence of liver cancer and disease progression in patients with chronic hepatitis B. The treatment also achieved significant viral suppression and improvement in liver fibrosis. This offers hope for individuals with chronic hepatitis B who are at risk of developing liver cancer.